L01BC07 azacitidine
ATC group of level 5 – chemical substance · in plain English: cancer medicines that stop cells from dividing
This site has the patient leaflet or the SPC of 16 medicines in this group.
- 5 prescription only (POM)
Active substance: Azacitidine – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01B Antimetabolites 182 medicines
- L01BC Pyrimidine analogues, antineoplastic antimetabolites 78 medicines
- L01BC07 azacitidine 16 medicines
- L01BC Pyrimidine analogues, antineoplastic antimetabolites 78 medicines
- L01B Antimetabolites 182 medicines
- L01 Antineoplastic agents 1,025 medicines
Medicines
Other groups of the same level
- L01BC01 cytarabine 5 medicines
- L01BC02 fluorouracil 11 medicines
- L01BC05 gemcitabine 9 medicines
- L01BC06 capecitabine 30 medicines
- L01BC08 decitabine 2 medicines
- L01BC52 fluorouracil, combinations 1 medicine
- L01BC53 tegafur, combinations 1 medicine
- L01BC59 trifluridine, combinations 2 medicines
Other names of the ATC group
- Czech: L01BC07 Azacitidin
- French: L01BC07 azacitidine
- German: L01BC07 Azacitidin
- Spanish: L01BC07 AZACITIDINA
- German: L01BC07 Azacitidin
- Italian: L01BC07 AZACITIDINA
- Polish: L01BC07 AZACYTYDYNA
- Turkish: L01BC07 azasitidin
- Portuguese (Brazil): L01BC07 Azacitidina
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01BC07
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
